Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics for Use in Pediatric Patients, and for Use Against Biothreat Pathogens

Melinta Therapeutics, LLC (Melinta), a company specializing in innovative therapies for acute and life-threatening illnesses, has joined forces with the Biomedical Advanced Research and Development Authority (BARDA) to advance two FDA-approved antibiotics, BAXDELA® and VABOMERE®, for pediatric use. Additionally, the partnership includes the development of BAXDELA® against biothreat pathogens. BA..